ctrl K

Price Alert

Elevation Oncology Inc. (ELEV)

NASDAQ: ELEV · Real-Time Price · USD

0.38

0.06 (18.79%)

At close: Jun 09, 2025, 3:59 PM

Elevation Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	49.46M	49.26M	45.92M	146.28M
Short-Term Investments	43.72M	33.85M	44.36M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	866K	1.07M	1.09M	31.96K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.54M	4.86M	2.7M	3.14M
Total Current Assets	94.73M	87.96M	92.98M	149.42M
Property-Plant & Equipment	34K	59K	98K	38K
Goodwill & Intangibles	n/a	59.00	98.00	38.00
Total Long-Term Assets	900K	1.13M	1.18M	70K
Total Assets	95.63M	89.09M	94.16M	149.49M
Account Payables	559K	507K	6.36M	5.65M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	2.27M	2.39M	n/a	n/a
Total Current Liabilities	4.47M	4.14M	15.69M	8.79M
Long-Term Debt	31.13M	30.14M	29.43M	n/a
Other Long-Term Liabilities	n/a	n/a	2K	8K
Total Long-Term Liabilities	31.13M	30.14M	29.44M	8K
Total Liabilities	35.6M	34.28M	45.13M	8.8M
Total Debt	31.13M	30.14M	29.43M	n/a
Common Stock	6K	4K	2K	2K
Retained Earnings	-240.46M	-195.97M	-150.27M	-55.19M
Comprehensive Income	61K	9K	-161K	-149.49M
Shareholders Equity	60.02M	54.81M	49.03M	140.7M
Total Investments	43.72M	33.85M	44.36M	n/a